MYELOID MALIGNANCIES
Clinical trials for MYELOID MALIGNANCIES explained in plain language.
Never miss a new study
Get alerted when new MYELOID MALIGNANCIES trials appear
Sign up with your email to follow new studies for MYELOID MALIGNANCIES, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo aims to stop blood cancer relapse after transplant in kids
Disease control Recruiting nowThis study tests whether giving two drugs (decitabine and filgrastim) after a stem cell transplant can safely prevent leukemia or related blood cancers from coming back in children and young adults. About 37 participants with acute myeloid leukemia, myelodysplastic syndromes, or …
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE2 • Sponsor: Franziska Wachter • Aim: Disease control
Last updated May 17, 2026 05:43 UTC
-
New drug may keep blood cancer at bay after transplant
Disease control Recruiting nowThis study tests the safety of a drug called olutasidenib given after a stem cell transplant to people with certain blood cancers (like AML or MDS) that have an IDH1 mutation. About 31 participants will take the drug as maintenance therapy to try to prevent the cancer from coming…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 05:35 UTC
-
Could a targeted pill boost transplant success in older blood cancer patients?
Disease control Recruiting nowThis phase 3 trial compares two conditioning regimens before stem cell transplant in adults over 50 with acute myeloid leukemia or myelodysplastic syndrome. One group gets standard chemotherapy (fludarabine + melphalan), the other adds venetoclax, a targeted pill. The goal is to …
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE3 • Sponsor: First Affiliated Hospital of Zhejiang University • Aim: Disease control
Last updated May 17, 2026 05:33 UTC
-
Engineered immune cells take aim at Hard-to-Treat leukemia
Disease control Recruiting nowThis study tests a new treatment for people with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) that has come back or not responded to standard therapy. The treatment uses specially engineered natural killer (NK) cells designed to recognize and attack cancer cells…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 17, 2026 05:32 UTC
-
Supercharged immune cells take on Hard-to-Treat blood cancers
Disease control Recruiting nowThis study tests a new treatment for people with myeloid cancers (like AML or MDS) that have come back or not responded to standard therapy. The treatment uses specially engineered natural killer (NK) cells from donated cord blood, designed to better target cancer cells and resis…
Matched conditions: MYELOID MALIGNANCIES
Phase: PHASE1, PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated May 11, 2026 20:52 UTC